Your session is about to expire
← Back to Search
Genomic-Guided Radiation Therapy for Breast Cancer
Study Summary
This trial will test whether a new way of giving radiation therapy, based on the DNA of a person's tumor, can help people with a certain type of breast cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had multiple treatments for my condition.I am not pregnant or breastfeeding.My breast cancer has spread to other parts of my body.I am not allergic to any of the drugs or their components used in this study.My surgery showed cancer cells at the edge of the tissue removed.My breast cancer is not driven by hormones.My breast cancer is confirmed as Triple Negative by a biopsy.I am 18 years old or older.My breast cancer does not show high levels of HER2.I have recovered from recent surgery and my surgeon has cleared me.I have recovered from any major surgery or significant injury at least 14 days before the study starts.I am committed to using effective birth control during the study.I can sign or have someone authorized to sign the consent form for me.I had a lumpectomy and my underarm lymph nodes were checked.My biopsy has enough tissue for the required test.You are expected to live for more than 16 weeks.I am mostly able to care for myself.
- Group 1: Radiosensitivity Index optimized
- Group 2: Radiosensitivity Index not optimized
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA authorised Genomically Guided Radiation Therapy for clinical use?
"Our team at Power provided Genomically Guided Radiation Therapy a score of 2 because this is presently in Phase 2, which means it has some evidence backing its safety but does not yet have any data supporting efficacy."
Are there any availabilities for individuals to take part in this trial?
"Clinicaltrials.gov confirms that this medical trial is actively seeking patients, with the initial posting occuring on November 4th 2022 and its most recent update taking place 10 days later."
How many participants have enrolled in this research endeavor?
"Affirmative. According to information published on clinicaltrials.gov, this medical trial began recruitment on November 4th 2022 and is still ongoing. A total of 86 study subjects need to be enrolled from a single site."
Share this study with friends
Copy Link
Messenger